![](/img/cover-not-exists.png)
1139PDNovel small-molecule RORγ agonist immuno-oncology agent LYC-55716: Safety and efficacy in a phase IIA open-label, multicenter trial
Wang, J, Liu, S V, Uronis, H E, Wu, C, Mahalingam, D, Spira, A, Carter, L, Hu, X, Weems, G, Wilkins, H J, Duska, L R, Kelly, KVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy288.012
Date:
October, 2018
File:
PDF, 93 KB
2018